Clinical Trial Update: Open Label Pharmacokinetic in Adult Patients With Ventilator-Associated Pneumonia [Phase 1]

View source ↗

Summary

Open-label pharmacokinetic study in adults with ventilator-associated pneumonia (Phase 1) has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ventilator-associated Pneumonia

Snippet

Sponsor: Basilea Pharmaceutica | Conditions: Ventilator Associated Pneumonia | Phase 1 | Status: TERMINATED